Your browser doesn't support javascript.
loading
Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by ß-arrestin.
Kahsai, Alem W; Shah, Kunal S; Shim, Paul J; Lee, Mason A; Shreiber, Bowie N; Schwalb, Allison M; Zhang, Xingdong; Kwon, Henry Y; Huang, Li-Yin; Soderblom, Erik J; Ahn, Seungkirl; Lefkowitz, Robert J.
Afiliación
  • Kahsai AW; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Shah KS; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Shim PJ; Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Lee MA; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Shreiber BN; Department of Medicine, College of Medicine, The University of Arizona, Phoenix, AZ 85004.
  • Schwalb AM; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Zhang X; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Kwon HY; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Huang LY; Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Soderblom EJ; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Ahn S; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Lefkowitz RJ; General Surgery Residency Program, Henry Ford Hospital, Detroit, MI 48202.
Proc Natl Acad Sci U S A ; 120(43): e2303794120, 2023 10 24.
Article en En | MEDLINE | ID: mdl-37844230
ß-arrestins are multivalent adaptor proteins that bind active phosphorylated G protein-coupled receptors (GPCRs) to inhibit G protein signaling, mediate receptor internalization, and initiate alternative signaling events. ß-arrestins link agonist-stimulated GPCRs to downstream signaling partners, such as the c-Raf-MEK1-ERK1/2 cascade leading to ERK1/2 activation. ß-arrestins have been thought to transduce signals solely via passive scaffolding by facilitating the assembly of multiprotein signaling complexes. Recently, however, ß-arrestin 1 and 2 were shown to activate two downstream signaling effectors, c-Src and c-Raf, allosterically. Over the last two decades, ERK1/2 have been the most intensely studied signaling proteins scaffolded by ß-arrestins. Here, we demonstrate that ß-arrestins play an active role in allosterically modulating ERK kinase activity in vitro and within intact cells. Specifically, we show that ß-arrestins and their GPCR-mediated active states allosterically enhance ERK2 autophosphorylation and phosphorylation of a downstream ERK2 substrate, and we elucidate the mechanism by which ß-arrestins do so. Furthermore, we find that allosteric stimulation of dually phosphorylated ERK2 by active-state ß-arrestin 2 is more robust than by active-state ß-arrestin 1, highlighting differential capacities of ß-arrestin isoforms to regulate effector signaling pathways downstream of GPCRs. In summary, our study provides strong evidence for a new paradigm in which ß-arrestins function as active "catalytic" scaffolds to allosterically unlock the enzymatic activity of signaling components downstream of GPCR activation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Arrestinas Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Arrestinas Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos